MEC '17: A Sense of What's to Come
MEC is a triennial symposium that will be of special interest to those who work in the fields of upper limb prosthetics and myoelectric control (including upper and lower limb). As in previous years, it will be hosted by the Institute of Biomedical Engineering, a research institute recognized worldwide for its pioneering work in myoelectric controls.
MEC ‘17 will be held in Fredericton, New Brunswick, August 14-18, 2017.
Please stay tuned for more details as they become available. To be alerted about upcoming preparations for MEC'17, please subscribe to the MEC email list. Courses and workshops geared towards clinicians, engineers, and researchers who work in the fields of upper limb prothetics and myoelectric control (including upper and lower limb) will be offered during MEC'17. Information will be posted on our website as the schedule is developed.
We are pleased to announce our three Keynote Speakers for MEC '17:
Dario Farina, PhD. is Full Professor and Founding Director of the Institute of Neurorehabilitation Systems at the University Medical Center Göttingen, Georg-August University, Germany. His research focuses on neurorehabilitation technology, neural control of movement, and biomedical signal processing and modelling. He is currently the Editor-in-Chief of the Journal of Electromyography and Kinesiology.
Jeff Tiessen, an amputee of nearly 40 years, is president and publisher of Disability Today Publishing Group (DTPG), a disability community pioneer and leader for over 25 years. Tiessen, a three-time Paralympic medallist and world record holder, award-winning journalist , and Canadian Disability Hall of Fame inductee, is a respected advocate and keenly aware of the informational needs of Canadians with limb loss through personal experience and a vast network of amputee colleagues, O&P practitioners, and industry partners.
Doug Weber, PhD. is an Associate Professor in the Department of Bioengineering at the University of Pittsburgh. Dr. Weber is also a Program Manager in the Biological Technologies Office (BTO) at the Defense Advanced Research Projects Agency (DARPA), where he is managing a portfolio of neuroscience and neurotechnology programs.